"We are pleased to have completed this round of strategic fund-raising and are grateful to FF&P, Imperial Innovations, Elaia Partners, Sitka Health Fund VCT Plc and all our other shareholders for their continued support," said Prof. Yike Guo, Founder and Chief Executive Officer of InforSense. "With these funds, we are well positioned to increase our growth rate and capitalize on the current success of our business."
David Donnelly, CEO FF&P Private Equity, added, "FF&P Private Equity is delighted to continue to support InforSense. The investment is in line with FF&P's philosophy of backing companies and management teams that are successfully delivering innovative technologies and products to the market. The Company is well placed to enjoy success in the years ahead."
"InforSense has shown tremendous growth in the last twelve months, with a rapidly growing customer base," said Susan Searle, CEO of Imperial Innovations. "We are delighted to be able to support them as they continue that growth with our largest single investment to date."
About FF&P Private Equity Limited
FF&P Private Equity provides its clients with the opportunity to invest in the equity of high growth, unquoted companies whose objective is to generate attractive returns through the subsequent listing, or trade sale, of these companies. FF&P Private Equity invests typically GBP 5 million to GBP 25 million of equity per transaction and places particular emphasis on backing commercial managers with a track record in successful execution of business plans and enhancing shareholder value. For further details see: www.ffandp.co.uk/private-equity
About Imperial Innovations Group plc
Imperial Innovations is one of the UK's leading technology transfer and commercialisation companies. The company was founded in 1986 and its ordinary shares admitted to trading on the AIM Market of London Stock Exchange plc in July 2006, raising GBP 26 million. The company's integrated approach encompasses the identification of ideas, protection of intellectual property, development and licensing of technology and formation, incubation and investment in spin-out companies. A wide range of technologies are commercialised within the areas of healthcare, energy, environment and emerging technology trends.
Website: www.imperialinnovations.co.uk
About InforSense
InforSense Ltd., the leader in integrative analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology, consumer goods, financial services companies, and research institutes are using the company's flagship product, InforSense KDE, to enhance productivity across life science R&D, healthcare, and business analytics. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.
For more information visit www.inforsense.com
InforSense, TextSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.
Contact: InforSense Ltd Tracy Coffey Donahue, +1 857 919 9975 Corporate Communications Officer tcdonahue@inforsense.com
Source: InforSense Ltd.
